Lymphangioma and congenital pulmonary lymphangiectasis: A histologic, immunohistochemical, and clinicopathologic comparison

Modern Pathology

Volumn 12, Issue 6, 1999, Pages 569-575

  Brown, Michael ^a   Pysher, Theodore ^a   Coffin, Cheryl M ^a,b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Lymphangiectasis; Lymphangioma; Vascular malformation

Indexed keywords

ACTIN; BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; COLLAGEN TYPE 4; DNA TOPOISOMERASE; PROTEIN BCL 2; VIMENTIN;

ADOLESCENT; ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LYMPHANGIECTASIS; LYMPHANGIOMA; MALE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK;

ADOLESCENT; ADULT; CELL DIVISION; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; LUNG DISEASES; LYMPHANGIECTASIS; LYMPHANGIOMA; LYMPHATIC SYSTEM; MALE; NEOPLASM RECURRENCE, LOCAL; TUMOR MARKERS, BIOLOGICAL; VASCULAR NEOPLASMS;

EID: 0033064398     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Coffin CM. Vascular tumors. In: Coffin CM, Dehner LP, O'Shea PA, editors. Pediatric soft tissue tumors. Baltimore: Williams & Wilkins; 1997. p. 40-4.
2. Coffin CM, Dehner LP. Soft tissue neoplasms in childhood and adolescence: a clinicopathologic review of 944 cases [abstract]. Lab Invest 1986;54:12A.
3. Anderson DH. Tumors of infancy and childhood. Cancer 1951;4:890-906.
4. Lawrence EA, Donlan EJ. Neoplastic diseases in infants and children. Cancer Res 1952;12:900-4.
5. Coffin CM, Dehner LP. Vascular tumors in children and adolescents: a clinicopathologic study of 228 tumors in 222 patients. Pathol Annu 1993;1:97-120.
6. Mukai K, Rosai J, Burgdorf WHC. Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol 1980;4:273-6.
7. Miettinen M, Hofthofer H, Lehto VP, Miettinen A, Virtanen I. Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. Am J Clin Pathol 1983;79:32-6.
8. Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol 1991;96:25-31.
9. de Young BR, Swanson PE, Argenyi ZB, Ritter JH, Fitzgibbon JF, Stahl DJ, et al. CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation. J Cutan Pathol 1995;22:215-22.
10. Waldo ED, Vuletin JC, Kaye GI. The ultrastructure of vascular tumors: additional observations and a review of the literature. Pathol Annu 1977;12:279-326.
11. Fukunaga M, Shimoda T, Nikaido T, Ushigome S, Ishikawa E. Soft tissue vascular tumors: a flow cytometric DNA analysis. Cancer 1993;71:2233-41.
12. Witte MH, Witte CL. Lymphangiogenesis and lymphologic syndromes. Lymphology 1986;19:21-8.
13. Levine C. Primary disorders of the lymphatic vessels: a unified concept. J Pediatr Surg 1989;24:233-40.
14. Smeltzer DM, Strickler GB, Gleming RE. Primary lymphatic dysplasia in children: chylothorax, chylous ascites, and generalized lymphatic dysplasia. Eur J Pediatr 1986;145:286-92.
15. Hilliard RI, McKendry JBJ, Phillips MJ. Congenital abnormalities of the lymphatic system: a new clinical classification. Pediatrics 1990;86:988-94.
16. France NE, Brown RJK. Congenital pulmonary lymphangiectasis: report of 11 examples with special reference to cardiovascular findings. Arch Dis Child 1971;46:528-32.
17. Moerman P, Vandenberghe K, Devlieger H, Van Hole C, Fryns JP, Lauweryns JM. Congenital pulmonary lymphangiectasis with chylothorax: a heterogeneous lymphatic vessel abnormality. Am J Med Genet 1993;47:54-8.
18. Goetsch E. Hygroma colli cysticum and hygroma axillare: pathologic and clinical study and report of 12 cases. Arch Surg 1938;36:394-479.
19. Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-64.
20. Mulliken JB, Zetter BR, Folkman J. In vitro characteristics of endothelium from hemangiomas and vascular malformations. Surgery 1982;92:348-53.
21. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-22.
22. Tanigawa N, Shimomatsuya T, Takahashi K, Inomata Y, Tanaka K, Satomura K, et al. Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion. Cancer 1987;60:741-9.
23. Yura J. Bleomycin treatment for cystic hygroma in children. Arch Jpn Chir 1977;9:191-5.
24. Thomson H. Cutaneous hemangiomas and lymphangiomas. Clin Plast Surg 1987;14:341-56.
25. Tesar F, Turner C, Sener BC, Sencift K. Lymphangioma treatment with Nd-YAG laser. Turk J Pediatr 1995;37:253-6.
26. Balakrishnan A, Bailey CM. Lymphangioma of the tongue: a review of pathogenesis, treatment, and the use of surface laser photocoagulation. J Laryngol Otol 1991;105:924-9.
27. Landthaler M, Hohenleutner U. Laser treatment of congenital vascular malformations. Int Angiol 1990;9:208-13.
28. Enzinger FM, Weiss SW. Benign tumors and tumor-like lesions of blood vessels. In: Enzinger FM, Weiss SW, editors. Soft tissue tumors. 3rd ed. St. Louis: Mosby; 1995. p. 579-626.
29. Gomez CS, Calonje E, Ferrar DW, Browse NL, Fletcher CD. Lymphangiomatosis of the limbs: clinicopathologic analysis of a series with a good prognosis. Am J Surg Pathol 1995;19: 125-33.
30. Sauter B, Foedinger D, Sterniczky B, Wolff K, Rappersberger K. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells: differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs. blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem 1998;46:165-76.
31. Brennan TD, Miller AS, Chen SY. Lymphangiomas of the oral cavity: a clinicopathologic, immunohistochemical, and electron microscopic study. J Oral Maxillofac Surg 1997;55: 932-5.
32. Collins Mil, Darragh RK, Caldwell RL, Turrentine MW, Brown JW. Short-term survivors of pediatric heart transplantation: an autopsy study of their pulmonary vascular disease. J Heart Lung Transplant 1995;14:1116-25.
33. Scalzetti EM, Heitzman ER, Groskin SA. Developmental lymphatic disorders of the thorax. Radiographies 1991;11:1069-85.
34. Joshi M, Cole S, Knibbs D, Diana D. Pulmonary abnormalities in Klippel-Trenaunay syndrome: a histologic, ultrastructural, and immunocytochemical study. Chest 1992;102:1274-7.
35. Tazelaar HD, Kerr D, Yousem SA, Saldana MJ, Langston C, Colby TV. Diffuse pulmonary lymphangiomatosis. Hum Pathol 1993;24:1313-22.
36. Mahle C, Schwartz M, Popek E, Bocklage T. Intra-abdominal lymphangiomas in children and adults: assessment of proliferative activity. Arch Pathol Lab Med 1997;121:1055-62.
37. Giorno R, Claman HN. Mast cells and neurofibromatosis. Neurofibromatosis 1988;1:100-4.
38. Johnson MD, Kamso-Pratt J, Federspiel CF, Whetsell WO Jr. Mast cell and lymphoreticular infiltrates in neurofibromas: comparison with nerve sheath tumors. Arch Pathol Lab Med 1989;113:1263-70.
39. Dethlefsen SM, Mulliken IB, Glowacki J. An ultrastructural study of mast cell interactions in hemangiomas. Ultrastruct Pathol 1986;10:175-83.
40. Pasyk KA, Cherry GW, Grabb WC, Sasaki GH. Quantitative evaluation of mast cells in cellularly dynamic and adynamic vascular malformations. Plast Reconstr Surg 1984;73:69-77.
41. Glowacki J, Mulliken JB. Mast cells in hemangiomas and vascular malformations. Pediatrics 1982;70:48-51.
42. Shea CR, Prieto VG. Mast cells in angiolipomas and hemangiomas of human skin: are they important for angiogenesis? J Cutan Pathol 1994;21:247-51.
43. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-64.
44. Koutlas IG, Jessurun J. Arteriovenous hemangioma: a clinicopathological and immunohistochemical study. J Cutan Pathol 1994;21:343-9.
45. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77:1033-79.
46. Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG, et al. Human mast cells stimulate vascular tube formation: tryptase is a novel, potent angiogenic factor. J Clin Invest 1997;99:2691-700.
47. Norrby K. Mast cells and de novo angiogenesis: angiogenic capability of individual mast-cell mediators such as histamine, TNF, IL-8, and bFGF. Inflamm Res 1997;46:57-58.
48. Rizzo V, de Fouw DO. Mast cell activation accelerates the normal rate of angiogenesis in the chick chorioallantoic membrane. Microvasc Res 1996;52:245-57.
49. Reed JA, Albino AP, McNutt NS. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995; 72:215-22.
50. Meininger CJ, Zetter BR. Mast cells and angiogenesis. Semin Cancer Biol 1992;3:73-9.
51. Norrby K, Sorbo J. Heparin enhances angiogenesis by a systemic mode of action. Im J Exp Pathol 1992;73:147-55.